I had an inkling that Brugger might have a continuing involvement with MNTA in some capacity when he chose to exercise 56K MNTA options without selling the new shares (#msg-56169633).
Today’s SEC filing does not say which private biotech company Brugger is joining as the CEO. If anyone knows, please post.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”